Defendant shall be punished by a fine of KRW 2,000,000.

When the defendant does not pay the above fine, 100,000 won.

Punishment of the crime

No one shall put a mark on the container, package or appended document that may lead to misunderstanding that an article other than a drug has efficacy, efficacy, or effect, or advertise such a content, and shall sell, store or display for sale, any article indicated or advertised similar to that of a drug.

Nevertheless, from January 2013 to May 15, 2015, the Defendant is using “D” Internet homepage operated by the Defendant for the purpose of stabilizing the separation uneasiness and the neeological stability appearing in the dog of stress.

Notice of "," etc., and with respect to "new smuggling," effective nutrition treatment system for diseases."

The phrase “improvements of efficacy values between acute and chronic diseases and inter-livers” was posted, and the phrase “scopic scopic scopic scopic scopic scopic scopics” was posted, thereby making an advertisement that may lead to misunderstanding of medical efficacy, effects, etc. of non-pharmaceuticals as having medical efficacy, effects, etc.

Summary of Evidence

1. Partial statement of the defendant;

1. E statements;

1. Details of advertising products;

1. Application of the Acts and subordinate statutes on the written accusation;

1. Article 93(1)10 and Article 61(2) of the former Pharmaceutical Affairs Act (Amended by Act No. 13114, Jan. 28, 2015) concerning criminal facts and the choice of punishment

1. The former part of Article 37 of the Criminal Act, and Articles 38 (1) 2 and 50 of the same Act, which aggravated concurrent crimes;

1. Article 70(1) and Article 69(2) of the Criminal Act to attract a workhouse;

1. Determination on the assertion by the Defendant and his defense counsel under Article 334(1) of the Criminal Procedure Act

1. The summary of the assertion was that the Defendant posted the same article as that stated in the facts charged on the Defendant’s Internet homepage, Inc., a corporation operating the Defendant, but the former part of Article 61(2) of the Pharmaceutical Affairs Act is “containers”, “spawn”, and “spawn”, respectively.